{
"METABOLOMICS WORKBENCH":{"STUDY_ID":"ST001391","ANALYSIS_ID":"AN002320","VERSION":"1","CREATED_ON":"May 28, 2020, 4:23 pm"},

"PROJECT":{"PROJECT_TITLE":"Metabolic Response in Patients with Post-Treatment Lyme Disease Symptoms/Syndrome","PROJECT_SUMMARY":"Sera from two small cohorts of patients were analyzed by untargeted liquid chromatography-mass spectrometry (LC-MS) to identify small molecule metabolites and metabolic pathways that differ between PTLDS and clinically cured (non-PTLDS) patients at baseline, following treatment completion and at one-year post-treatment.","INSTITUTE":"Colorado State University","LAST_NAME":"Belisle","FIRST_NAME":"John","ADDRESS":"200 West Lake, Campus Delivery 0922, Colorado State University, Fort Collins, CO, 80523, USA","EMAIL":"john.belisle@colostate.edu","PHONE":"9704915384"},

"STUDY":{"STUDY_TITLE":"Metabolic Response in Patients with Post-Treatment Lyme Disease Symptoms/Syndrome","STUDY_SUMMARY":"Post-treatment Lyme Disease Symptoms/Syndrome (PTLDS) occurs in approximately 10% of Lyme disease patients following antibiotic treatment. Objective biomarkers or specific clinical symptoms to identify PTLDS patients do not currently exist and the PTLDS classification is based on the report of persistent subjective symptoms for ≥ 6 months following antibiotic treatment for Lyme disease. Untargeted liquid chromatography-mass spectrometry metabolomics was used to define metabolic changes that occurred longitudinally in PTLDS and clinically cured non-PTLDS Lyme patients from two separate cohorts. An elastic net regularization model was applied to define the metabolites that classified PTLDS and non-PTLDS patients at different time points, and the PTLDS defining metabolites were evaluated in two sample cohorts using linear discriminant analysis. This study determined that observable metabolic alterations occur between PTLDS and non-PTLDS patients at multiple time points. These metabolic alterations discriminated between PTLDS and non-PTLDS patients and consisted of metabolites of glycerophospholipid, bile acid and acylcarnitine metabolism. Longitudinal analyses showed distinct patterns in metabolite abundance changes that indicated a greater variability in PTLDS vs non-PTLDS patients. These data provide evidence that an objective metabolite-based measurement can distinguish patients with PTLDS and help understand the underlying biochemistry of PTLDS.","INSTITUTE":"Colorado State University","DEPARTMENT":"MIP","LABORATORY":"Belisle","LAST_NAME":"Belisle","FIRST_NAME":"John","ADDRESS":"200 West Lake, Campus Delivery 0922, Colorado State University, Fort Collins, CO, 80523","EMAIL":"john.belisle@colostate.edu","PHONE":"9704915384"},

"SUBJECT":{"SUBJECT_TYPE":"Human","SUBJECT_SPECIES":"Homo sapiens","TAXONOMY_ID":"9606"},
"SUBJECT_SAMPLE_FACTORS":[
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_10B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_10OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_10PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_11B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_11OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_11PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_12B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"20-29","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_12OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"20-29","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_12PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"20-29","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_13B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_13OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_13PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_14B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_14OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_14PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_15B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_15OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_15PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_16B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_16OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_16PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_17B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"20-29","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_17OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"20-29","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_17PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"20-29","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_18B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_18OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_18PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_19B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"70-79","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_19OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"70-79","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_19PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"70-79","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_1B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_1OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_1PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_20B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_20OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_20PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_21B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_21OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_21PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_22B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_22OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_22PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_23B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_23OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_23PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_24B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_24OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_24PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_25B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"60-69","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_25OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"60-69","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_25PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"60-69","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_26B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_26OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_26PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_2B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"20-29","Gender":"F","Race":"Nonwhite, black or hispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Equ","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_2PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"20-29","Gender":"F","Race":"Nonwhite, black or hispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_3B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"70-79","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_3OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"70-79","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_3PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"70-79","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Neg","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_4B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_4OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_4PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_5B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"30-39","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_5OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"30-39","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_5PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"30-39","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_6B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_6OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_6PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early disseminated Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_7PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"20-29","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_8B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"20-29","Gender":"F","Race":"Black, Hispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_8OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"20-29","Gender":"F","Race":"Black, Hispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_8PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"20-29","Gender":"F","Race":"Black, Hispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Equ","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_9B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_9OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"NA","Lyme EIA/ELISA Result":"NA","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_JHU_9PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"JHU","Sample Type":"Early localized Lyme","Cohort":"2","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Vls-E-1/PepC10 (QUEST)","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_10B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_10OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_10PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_11B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"70-79","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_11OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"70-79","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_11PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"70-79","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_12B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_12OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_12PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_13B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_13PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_14B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_14OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_14PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_15B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_15OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_15PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_17B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_17OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_17PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_18B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"60-69","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_18OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"60-69","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_18PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"60-69","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_19B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"30-39","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_19OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"30-39","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_19PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"30-39","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_1B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_1OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_1PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_20B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_20OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_20PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_21B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_21OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_21PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"30-39","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_22B",
"Factors":{"Time point":"Baseline","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"30-39","Gender":"F","Race":"Asian","Lyme EIA/ELISA Method":"C6","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_22PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"Yes"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"30-39","Gender":"F","Race":"Asian","Lyme EIA/ELISA Method":"C6","Lyme EIA/ELISA Result":"pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_2B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_2OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_2PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_3B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_3OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_3PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_4B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"60-69","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_4OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"60-69","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_4PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"60-69","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_5B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"pos","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_5OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_5PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"50-59","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_6B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"20-29","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_6OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"20-29","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_6PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"20-29","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_7B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Neg","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_7OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_7PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"50-59","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_8B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"60-69","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_8OYFU",
"Factors":{"Time point":"One-year follow-up","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"60-69","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"NA","Lyme IgG":"NA"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_8PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early localized Lyme","Cohort":"1","Age":"60-69","Gender":"F","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Neg","Lyme IgM":"Pos","Lyme IgG":"Pos"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_9B",
"Factors":{"Time point":"Baseline","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Neg"}
},
{
"Subject ID":"-",
"Sample ID":"PTLDS_NYMC_9PT",
"Factors":{"Time point":"Post-treatment","PTLDS":"No"},
"Additional sample data":{"Sample Provider":"NYMC","Sample Type":"Early disseminated Lyme","Cohort":"1","Age":"40-49","Gender":"M","Race":"White, NonHispanic","Lyme EIA/ELISA Method":"Wampole","Lyme EIA/ELISA Result":"Pos","Lyme IgM":"Pos","Lyme IgG":"Pos"}
}
],
"COLLECTION":{"COLLECTION_SUMMARY":"Sera (both cohorts) were collected at the time of diagnosis (baseline); at the completion of antibiotic therapy, approximately two to three weeks following diagnosis (post-treatment); and at one-year post-treatment (one-year follow-up). PTLDS (symptoms) patients were classified as such if symptoms developed at or within 6 months following diagnosis and persisted for at least 6 months following the completion of antibiotic therapy. Patients were classified as PTLDS (syndrome) if they met the above criteria and with daily life functional impairment reported.","SAMPLE_TYPE":"Blood (serum)"},

"TREATMENT":{"TREATMENT_SUMMARY":"N/A"},

"SAMPLEPREP":{"SAMPLEPREP_SUMMARY":"Serum samples were randomized prior to extraction of small molecule metabolites and LC-MS analyses. Metabolites were extracted with 75% methanol as previously described. Extracted metabolites were analyzed by LC-MS.","SAMPLEPREP_PROTOCOL_COMMENTS":"doi:10.1038/nprot.2011.335"},

"CHROMATOGRAPHY":{"CHROMATOGRAPHY_TYPE":"Reversed phase","INSTRUMENT_NAME":"Agilent 6520","COLUMN_NAME":"Poroshell 120 EC-C8 (100 x 2.1mm, 2.5um)","FLOW_GRADIENT":"2-98% non-linear gradient","FLOW_RATE":"0.25 ml/min","COLUMN_TEMPERATURE":"50","SOLVENT_A":"water, 0.1% formic acid","SOLVENT_B":"acetonitrile, 0.1% formic acid"},

"ANALYSIS":{"ANALYSIS_TYPE":"MS"},

"MS":{"INSTRUMENT_NAME":"Agilent 6520 QTOF","INSTRUMENT_TYPE":"QTOF","MS_TYPE":"ESI","ION_MODE":"POSITIVE","MS_COMMENTS":"LC-MS data were processed with MassHunter Profinder version B.08.00 and Mass Profiler Professional version B.14.9.01 (Agilent Technologies) to identify differentiating molecular features (MFs; metabolites defined by a retention time and accurate mass) between PTLDS and non-PTLDS patients at baseline, post-treatment and one-year follow-up in cohort-one. The biosignature-MFs determined using cohort-one were targeted in patient samples from cohort-two using MassHunter Profinder.","CAPILLARY_VOLTAGE":"4000","DRY_GAS_FLOW":"10 l/min","DRY_GAS_TEMP":"310","FRAGMENT_VOLTAGE":"120","NEBULIZER":"45 psi","OCTPOLE_VOLTAGE":"750 V","MS_RESULTS_FILE":"ST001391_AN002320_Results.txt UNITS:counts Has m/z:Neutral masses Has RT:Yes RT units:Minutes"}

}